The report will be delivered in 2-3 business days.

Psoriasis Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7040 | Format :


The psoriasis drugs market consists of sales of psoriasis drugs. Psoriasis is a persistent skin disorder which causes distress and pain through patches of abnormal skin. Psoriasis can be caused due to injuries to skin, medications, genetics, infection, diet, weather, etc. The drugs vary depending on the severity of the infection and provide relief from infections. Examples of drugs in the psoriasis market include Clobetasol (Temovate), triamcinolone (Aristocort), fluocinolone (Synalar), and betamethasone (Diprolene).

The global psoriasis market was valued at about $30.13 billion in 2018 and is expected to grow to $46.57 billion at a CAGR of 11.5% through 2022.

North America was the largest region in the psoriasis drugs market in 2018. This region is expected to remain the largest during the next five years. The psoriasis drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

The rise in the prevalence of psoriasis patients is driving the Psoriasis market. Psoriasis is caused due to immune system, genetics and environment. The rise in psoriasis patients in the past few years can be mainly attributed to climate change, stress and unhealthy lifestyle. According to the World Health Organization (WHO), psoriasis had affected at least 100 million individuals worldwide in 2016.

The high cost of psoriasis therapy is a restraint for the psoriasis market. According to a study conducted by JAMA Dermatology in 2019, the typical psoriasis treatments with biologics are very costly, ranging between $10,000 and $25,000 per year. The high cost is because patent protections are preventing many alternative drugs.

Combination therapy is an emerging trend in the psoriasis market. Combination therapy is an f treatment that combines two different psoriasis treatments at the same time. When two drugs with different mechanisms of action are combined (combination therapy), the effect is greater than that obtained by monotherapy (treatment with a single drug). Studies suggest that combination therapy eases psoriasis symptoms more effectively than a single therapy and has lesser side effects. An example of combination therapy for the treatment of active psoriatic arthritis (PsA) is taltz (ixekizumab) with methotrexate developed by Eli Lilly and Company.

The process of approval of psoriasis drugs is becoming easier globally. This is evident from the increasing approvals of drugs for psoriasis in the recent years. Some of the examples include the first regulatory approval of SKYRIZI™ (risankizumab) for the treatment of plaque psoriasis in Japan in 2019, and the approval of a new treatment for plaque psoriasis in Europe in 2018. Hence, the increasing ease of drug approvals is expected to drive the psoriasis drugs market in the coming years.

Major players in the market are AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly and Company and Celgene Corporation.

    1. Executive Summary

    2. Psoriasis Drugs Market Characteristics

    3. Psoriasis Drugs Market Size And Growth

    3.1. Global Psoriasis Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Psoriasis Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Psoriasis Drugs Market Segmentation

    4.1. Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Interleukin Inhibitors

    Corticosteroids

    Anti-Inflammatory

    Tumor Necrosis Factor Inhibitor

    4.2. Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals

    Retail Pharmacies

    E-commerce

    4.3. Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Small Molecules

    Biologics

    4.4. Global Psoriasis Drugs Market, Segmentation  By Route Of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Oral

    Tropical

    Injectable

    4.5. Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Plaque Psoriasis

    Nail Psoriasis

    Guttate Psoriasis

    Pustular Psoriasis

    Erythrodermic Psoriasis

    5. Psoriasis Drugs Market Regional And Country Analysis

    5.1. Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Psoriasis Drugs Market  

    6.1. Asia-Pacific Psoriasis Drugs Market Overview  

    6.2. Asia-Pacific Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Psoriasis Drugs Market  

    7.1. China Psoriasis Drugs Market Overview  

    7.2. China Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Psoriasis Drugs Market  

    8.1. India Psoriasis Drugs Market Overview  

    8.2. India Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Psoriasis Drugs Market  

    9.1. Japan Psoriasis Drugs Market Overview  

    9.2. Japan Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Psoriasis Drugs Market  

    10.1. Australia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Psoriasis Drugs Market  

    11.1. Indonesia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Psoriasis Drugs Market  

    12.1. South Korea Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Psoriasis Drugs Market  

    13.1. Western Europe Psoriasis Drugs Market Overview

    13.2. Western Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Psoriasis Drugs Market  

    14.1. UK Psoriasis Drugs Market Overview

    14.2. UK Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Psoriasis Drugs Market  

    15.1. Germany Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Psoriasis Drugs Market  

    16.4. France Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Psoriasis Drugs Market  

    17.1. Eastern Europe Psoriasis Drugs Market Overview

    17.2. Eastern Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Psoriasis Drugs Market  

    18.1. Russia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Psoriasis Drugs Market  

    19.1. North America Psoriasis Drugs Market Overview

    19.2. North America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Psoriasis Drugs Market  

    20.1. USA Psoriasis Drugs Market Overview

    20.2. USA Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Psoriasis Drugs Market  

    21.1. South America Psoriasis Drugs Market Overview

    21.2. South America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Psoriasis Drugs Market  

    22.1. Brazil Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Psoriasis Drugs Market  

    23.1. Middle East Psoriasis Drugs Market Overview

    23.2. Middle East Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Psoriasis Drugs Market  

    24.1. Africa Psoriasis Drugs Market Overview

    24.2. Africa Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Psoriasis Drugs Market Competitive Landscape And Company Profiles

    25.1. Psoriasis Drugs Market Competitive Landscape

    25.2. Psoriasis Drugs Market Company Profiles

    25.2.1. AbbVie Inc.

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Pfizer Inc.

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Novartis

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Eli Lilly and Company.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Celgene Corporation

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Psoriasis Drugs Market

    27. Psoriasis Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Psoriasis Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Psoriasis Drugs Market, Segmentation  By Route Of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: India, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Japan, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Australia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Australia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Indonesia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Indonesia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: South Korea, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: South Korea, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Western Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Western Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: UK, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: UK, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: Germany, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: Germany, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: France, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: France, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Eastern Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: Russia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: Russia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: North America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: North America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: USA, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: USA, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: South America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: South America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Brazil, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Brazil, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Middle East, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Middle East, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Africa, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: Africa, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: AbbVie Inc. Financial Performance
  • Table 49: Pfizer Inc. Financial Performance
  • Table 50: Novartis Financial Performance
  • Table 51: Eli Lilly and Company. Financial Performance
  • Table 52: Celgene Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Psoriasis Drugs Market, Segmentation  By Route Of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: India, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Japan, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Australia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Australia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Indonesia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: South Korea, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: South Korea, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Western Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: UK, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: UK, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: Germany, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: Germany, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: France, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: France, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Eastern Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: Russia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: Russia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: North America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: North America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: USA, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: USA, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: South America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: South America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Brazil, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Brazil, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Middle East, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Middle East, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Africa, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: Africa, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: AbbVie Inc. Financial Performance
  • Figure 49: Pfizer Inc. Financial Performance
  • Figure 50: Novartis Financial Performance
  • Figure 51: Eli Lilly and Company. Financial Performance
  • Figure 52: Celgene Corporation Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)